LONG-ACTING INJECTABLE ANTIPSYCHOTIC ADHERENCE AMONG TEXAS MEDICAID ENROLLEES WITH SCHIZOPHRENIA

被引：0
|
作者：
Chen, S. [1 ]
Barner, J. C. [1 ]
Crismon, M. L. [1 ]
Richards, K. M. [1 ]
Smith, T. L. [1 ]
机构：
[1] Univ Texas Austin, Austin, TX USA
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCR15
引用
收藏
页码：S314 / S315
页数：2
相关论文
共 50 条
  • [31] LONG-ACTING INJECTABLE ANTIPSYCHOTICS IN THE TREATMENT OF SCHIZOPHRENIA
    Fleischhacker, W. W.
    EUROPEAN PSYCHIATRY, 2013, 28
  • [32] The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
    Miyamoto S.
    Wolfgang Fleischhacker W.
    Current Treatment Options in Psychiatry, 2017, 4 (2) : 117 - 126
  • [33] Long-acting injectable risperidone for the treatment of schizophrenia
    Moeller, Hans-Juergen
    DRUGS, 2007, 67 (11) : 1541 - 1566
  • [34] Two Long-Acting Injectable Antipsychotics for Schizophrenia
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2015, 57 (1481): : 152 - 153
  • [35] A Concierge Model of Customized Adherence Enhancement Plus Long-Acting Injectable Antipsychotic in Individuals With Schizophrenia at Risk for Treatment Non-Adherence and for Homelessness
    Sajatovic, Martha
    Ramirez, Luis
    Fuentes-Casiano, Edna
    Cage, Jamie
    Tatsuoka, Curtis
    Bukach, Ashley
    Cassidy, Kristin
    Levin, Jennifer
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 : S403 - S404
  • [36] Long-Acting Antipsychotic Medication and the Outcome of Schizophrenia
    David, Anthony S.
    Gibbs, Ayana
    Patel, Maxine X.
    ADVANCES IN SCHIZOPHRENIA RESEARCH 2009, 2010, : 403 - +
  • [37] QUALITATIVE DIFFERENCES IN LONG ACTING INJECTABLE ANTIPSYCHOTIC MEDICATIONS AMONG SCHIZOPHRENIA PATIENTS
    Karakasi, Valeria
    Pavlidis, Pavlos
    Vlachaki, Aikaterini
    SCHIZOPHRENIA BULLETIN, 2020, 46 : S295 - S295
  • [38] Treatment patterns in Medicaid patients with schizophrenia initiated on a first- or second-generation long-acting injectable versus oral antipsychotic
    Pilon, Dominic
    Joshi, Kruti
    Tandon, Neeta
    Lafeuille, Marie-Helene
    Kamstra, Rhiannon L.
    Emond, Bruno
    Lefebvre, Patrick
    PATIENT PREFERENCE AND ADHERENCE, 2017, 11 : 619 - 629
  • [39] A Single Assessment with the Brief Adherence Rating Scale (BARS) Discriminates Responders to Long-acting Injectable Antipsychotic Treatment in Patients with Schizophrenia
    Byerly, Matthew
    Nakonezny, Paul
    McEvoy, Joseph
    Hamer, Robert
    Swartz, Marvin
    Rosenheck, Robert
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S381 - S382
  • [40] Treatment adherence in schizophrenia using risperidone long-acting injectable: as early as possible, as long as possible
    Viala, A.
    Boulicot, V.
    Merlot, A.
    Pinede, D.
    Vacheron, M. N.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S516 - S517
12345